Randomized, double-blind, placebo-controlled trial to evaluate the effects of adjunctive treatment with Aripiprazole on body weight, metabolic parameters, clinical efficacy, and adverse events in people with psychotic disorders on treatment with Clozapine
Latest Information Update: 20 Sep 2016
Price :
$35 *
At a glance
- Drugs Aripiprazole (Primary) ; Clozapine
- Indications Metabolic syndrome; Psychotic disorders; Weight gain
- Focus Therapeutic Use
- 12 Sep 2016 Status changed from not yet recruiting to recruiting.
- 13 Mar 2013 New trial record